Icon

VIREAD (nda021356)- (150MG,200MG,250MG,300MG)

TENOFOVIR DISOPROXIL FUMARATE GILEAD SCIENCES INC
150MG,200MG,250MG,300MG
Yes No
2018-Jan-25 Expired
2017-Mar-24 None
None No
VIREAD is a nucleotide analog HIV-1 reverse transcriptase inhibitor and an HBV reverse transcriptase inhibitor and is indicated: • in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 2 years of age and older weighing at least 10 kg. • for the treatment of chronic hepatitis B in adults and pediatric patients 2 years and older weighing at least 10 kg.
11 1 7
Total Other Developers 11
Drugs with Suitability No
150MG ** ** - - -
200MG ** ** - - -
250MG ** ** - - -
300MG ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** ********* ****** ******* *********** ****-***, **. **.*** & ***, **********, ********** ******, *******-********** ********, *******, ********* ******, ***** (***) ***
****** ********* ****** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** **** ******** ****** ************** **., ***. *** *********** **. ** ******* ****** ***** ******, ******, ******** ******, ***** (***) ***
****** **** **** ************** **., ***.(**** **** **** ****) *********** **.***, ****** ****, ****-**** ****, *****, ******** ******, ***** (***) ***
****** ***** ***** ******* *********** **** ** ****, *-*** ** *-***, *-*** ** *-***, **** ** *-***/*/*/*, *-****, *-***, *-***, *-***, ***** ********** ****, ********, *** ******, ***** (***) ***
****** ***** ***** ******* *** *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** ***** ***** ******* *********** **** *-*, *-**, *-** **** ********** ****, ******** *******, ******-*****, ****, *********** ******, ***** (***) ***
****** ****** **** *** *** ****** **** ******* *********** **** ***, **** **. **-***, ****-**, ***, **********, *********, ********* ******, ***** (***) ***
****** ******* ****** ******* ****** ******* ******* *********** ** **/*,******************, ********* *****, ****** *****, *********, ********* ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** **-**, ****** ** *** ******* ********** ****** ********, *****, ***** ******, ***** (***) ***
****** ******** ****** *** ******** *************** ******* *********** **** ** *-** ** *-**-* ******, ******* ******** ****,***** **, *********., ****, ****** ******* ******, ***** (***) ***
****** ********* ********* *************** *******, ***. *********** ** ******* *****, *** ***** ******, *******, *** **** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.